Growth failure
Gene: GLI2
Culler-Jones syndrome (CJS) is characterized by hypopituitarism, mainly growth hormone deficiency, and/or postaxial polydactyly. The phenotype is highly variable, and some individuals may have midline facial defects and developmental delay. The disorder shows incomplete penetrance and variable expressivity. Multiple families reported, short stature is a feature as a result of GH deficiency.
Variants in GLI2 are also associated with HPE, at least 5 families reported. Short stature is observed more rarely, as a result of midline defect.Created: 24 Aug 2021, 4:46 a.m. | Last Modified: 24 Aug 2021, 4:46 a.m.
Panel Version: 0.320
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Culler-Jones syndrome, MIM#615849; Holoprosencephaly 9, MIM# 61082)
Publications
Gene: gli2 has been classified as Green List (High Evidence).
Phenotypes for gene: GLI2 were changed from Holoprosencephaly, hypopituitarism to Culler-Jones syndrome, MIM#615849; Holoprosencephaly 9, MIM# 61082
Publications for gene: GLI2 were set to
Gene: gli2 has been classified as Green List (High Evidence).
gene: GLI2 was added gene: GLI2 was added to Growth failure in early childhood. Sources: Genomics England PanelApp,Expert Review Red Mode of inheritance for gene: GLI2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: GLI2 were set to Holoprosencephaly, hypopituitarism